Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement and complement regulatory proteins as potential molecular targets for vascular diseases.

Juan Acosta1, Xuebin Qin, Jose Halperin

  • 1Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, USA.

Current Pharmaceutical Design
|February 3, 2004
PubMed
Summary

Complement activation by-products and regulatory proteins contribute to vascular diseases like atherosclerosis and diabetes. Targeting these complement components offers a promising strategy for developing new mechanism-specific therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis.

Frontiers in immunology·2026
Same author

The Reconstitution of the Macrophage Niche Reveals Dynamic Transcriptional and Renal Macrophage-Epithelial Communication Networks.

Cells·2026
Same author

Glycated CD59, a Novel Biomarker for Gestational Diabetes.

Endocrine reviews·2026
Same author

An Unusual Case of Pacemaker-Mediated Tachycardia With Alternating Ventricular Capture. What Is the Mechanism?

Journal of cardiovascular electrophysiology·2026
Same author

Rapid Podocyte ablation Causes Acute Renal Tubule Cell Necrosis and Interstitial Fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Persistent activation of monocytes/macrophages and cell senescence in SIV-infected macaques on ART.

Frontiers in immunology·2026

Area of Science:

  • Immunology
  • Vascular Biology
  • Pathophysiology

Background:

  • Complement activation by-products and regulatory proteins are implicated in vascular pathologies.
  • Autologous complement-mediated damage occurs via cascade products or membrane attack complex (MAC) insertion.
  • MAC insertion into endothelial cells triggers growth factor/cytokine release, promoting vascular proliferation, inflammation, and thrombosis.

Purpose of the Study:

  • To review the role of complement and its regulators in vascular diseases.
  • To highlight complement as a therapeutic target for prevalent human diseases.

Main Methods:

  • Literature review focusing on complement pathways and vascular disease mechanisms.
  • Analysis of the pathogenic role of complement activation products and regulatory proteins.

Related Experiment Videos

Main Results:

  • Complement system components are key players in atherosclerosis, ischemia-reperfusion injury, graft rejection, vasculitis, and diabetic vascular complications.
  • Endothelial cell activation by MAC leads to pro-inflammatory and pro-thrombotic responses.

Conclusions:

  • The complement system and its regulators are critical in vascular disease pathogenesis.
  • Targeting complement pathways presents a rational approach for developing novel therapeutic strategies for vascular diseases.